Tottenham's Injury Woes: De Zerbi Defends Medical Team Amid Chelsea Clash
Tottenham manager Roberto De Zerbi insists the club's medical team is not to blame for the team's injury issues ahead of their match against Chelsea.

In Brief
- •Tottenham manager Roberto De Zerbi insists the club's medical team is not to blame for the team's injury issues ahead of their match against Chelsea.
- •De Zerbi reported that Pedro Porro, Andy Robertson, Omar Marmoush, and Dominic Solanke are fit, while players like Destiny Udogie, Tosin Adarabioyo, James Maddison, and Dejan Kulusevski are doubts or out.
- •De Zerbi highlighted the club's new performance director and medical staff, arguing that the injury situation is normal in football.
- •Tottenham aims to win their second match in 42 games against Chelsea at Stamford Bridge.
Why It Matters
Tottenham's injury woes and the club's response to these issues are crucial for their upcoming match against Chelsea. The team's ability to manage injuries and maintain performance is a key factor in their chances of success. The club's new performance director and medical staff are under scrutiny, and their ability to handle the situation will be a significant factor in the match outcome.
Key Details
- Injured Players
- 9
- Last Win
- 42 matches ago
- New Performance Director
- Dan Lewindon
Context & Background
Tottenham has struggled with a series of injuries, which has affected their performance in recent matches. The club has appointed a new performance director and has made several new hires in the performance department to address these issues.
Original Reporting & Sources
VNews is an independent briefing product. Original reporting remains credited to the following publishers:
This brief was synthesized automatically using attributed third-party reporting. VNews is a digital news publication produced under the VContent Group brand and operated by Francis Vincent Sunday in Ghana, independent from the publishers cited above. Read our AI Transparency Policy and Editorial & Corrections Policy.